Literature DB >> 7969416

Ribozymes. Hammerhead nailed down.

T R Cech, O C Uhlenbeck.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7969416     DOI： 10.1038/372039a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Generation of a ribozyme-adenoviral vector against K-ras mutant human lung cancer cells.

Authors:  Y A Zhang; J Nemunaitis; A W Tong
Journal:  Mol Biotechnol       Date:  2000-05       Impact factor: 2.695

2.  Ribozyme as an approach for growth suppression of human pancreatic cancer.

Authors:  H Kijima; K J Scanlon
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

3.  Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes.

Authors:  Renu Wadhwa; Hiroshi Ando; Hiroaki Kawasaki; Kazunari Taira; Sunil C Kaul
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 4.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

5.  A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo.

Authors:  S P Lyngstadaas; S Risnes; B S Sproat; P S Thrane; H P Prydz
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

Review 6.  Coenzymes and Their Role in the Evolution of Life.

Authors:  Andreas Kirschning
Journal:  Angew Chem Int Ed Engl       Date:  2020-10-23       Impact factor: 15.336
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.